NASDAQ: CAICaris Life Sciences Inc Stock Ownership - Who owns Caris Life Sciences?
Insider buying vs selling
Have Caris Life Sciences Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| T. Danny Phillips | Director | 2025-09-11 | 100,000 | $2.44 | $244.00kBuy |
| David Baxley Spetzler | President | 2025-08-11 | 63,509 | $29.75 | $1.89MSell |
| David D. Halbert | Founder Chairman and Chief Executive Officer | 2025-08-11 | 141,956 | $29.75 | $4.22MSell |
| George Poste | Director | 2025-08-11 | 125,000 | $2.44 | $305.00kBuy |
| George Poste | Director | 2025-08-11 | 48,022 | $29.75 | $1.43MSell |
| George Poste | Director | 2025-08-11 | 91,495 | $29.75 | $2.72MSell |
| David Baxley Spetzler | President | 2025-06-20 | 34,782 | $27.25 | $947.81kSell |
| Brian J. Brille | Vice Chairman and Executive Vice President | 2025-06-20 | 30,000 | $21.00 | $630.00kBuy |
| John Russel Denton | Senior Vice President General Counsel and Secretary | 2025-06-20 | 7,500 | $21.00 | $157.50kBuy |
| David Baxley Spetzler | President | 2025-06-20 | 75,000 | $2.44 | $183.00kBuy |
CAI insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CAI insiders and whales buy or sell their stock.
CAI Shareholders
What type of owners hold Caris Life Sciences Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| David D. Halbert | 49.63% | 139,583,602 | $4.20B | Insider |
| Tssp Subfund Holdco LLC | 8.67% | 24,385,399 | $733.51M | Insider |
| Sixth Street Partners Management Company LP | 8.67% | 24,385,399 | $733.51M | Institution |
| J H Whitney VI L P | 7.20% | 20,256,615 | $609.32M | Insider |
| Adapt I Ltd | 6.02% | 16,943,232 | $509.65M | Insider |
| Peter M. Castleman | 3.69% | 10,387,035 | $312.44M | Insider |
| Coatue Management LLC | 3.61% | 10,142,198 | $305.08M | Institution |
| Fmr LLC | 3.07% | 8,631,545 | $259.64M | Institution |
| Braidwell LP | 2.60% | 7,316,142 | $220.07M | Institution |
| T Rowe Price Investment Management Inc | 2.60% | 7,303,987 | $219.70M | Institution |
CAI vs Diagnostic & Research Stocks
Caris Life Sciences Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.